Related Experiment Video

Updated: Jul 6, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.6K

[Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract. German version]

G Baretton1, F Lordick2,

  • 1Institut für Pathologie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. gustavo.baretton@ukdd.de.

Pathologie (Heidelberg, Germany)
|January 3, 2024
PubMed
Summary

The increasing complexity of immuno-oncology treatments for upper gastrointestinal cancers necessitates standardized PD-L1 (programmed cell death-ligand 1) testing. Expert recommendations address challenges in diagnostic implementation, standardization, and interpretation for better patient stratification.

Keywords:
Esophageal squamous cell carcinomaGastric adenocarcinomaGastroesophageal junction adenocarcinomaImmune checkpoint inhibitorPD-L1 testingPredictive biomarkers

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
129